Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shields

Showing results (431-440 of 533) with videos related to

Pageof 54
Sort By:
Diabetologia|June 5, 2024
Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approachLaura M Güdemann, Katie G Young, Nicholas J M Thomas, et al.
American Journal of Pharmaceutical Education|December 5, 2017
Report of the 2016-2017 Student Affairs Standing CommitteeRenae J Chesnut, Iqbal I Atcha, Duc P Do, et al.
Diabetes Care|October 14, 2025
Updating a Clinical Prediction Model for Identifying Monogenic Diabetes to Include Both Clinical Features and BiomarkersJulieanne Knupp, Pedro Cardoso, Katherine G Young, et al.
The Lancet. Primary Care|May 11, 2026
Kidney outcomes with GLP-1 receptor agonists in people with type 2 diabetes already receiving SGLT2 inhibitors: a target trial emulation study using UK primary care dataThijs T Jansz, Andrew P McGovern, Katherine G Young, et al.
The Journal of Clinical Investigation|November 17, 2007
CD200 is induced by ERK and is a potential therapeutic target in melanomaKimberly B Petermann, Gabriela I Rozenberg, Daniel Zedek, et al.
The American Journal of Tropical Medicine and Hygiene|October 17, 2022
What Heterogeneities in Individual-level Mobility Are Lost During Aggregation? Leveraging GPS Logger Data to Understand Fine-scale and Aggregated Patterns of MobilityKathryn L Schaber, Tamaki Kobayashi, Marisa Hast, et al.
Diabetes, Obesity & Metabolism|June 4, 2026
Trends in Second-Line Initiations and Treatment Outcomes Across Age and Frailty Groups in People With Type 2 Diabetes: UK Population-Based Study, 2019-2024M M Dinsdale, K G Young, P Cardoso, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 3, 2009
Integration of racial, cultural, ethnic, and socioeconomic factors into a gastrointestinal pathophysiology courseHelen M Shields, Daniel A Leffler, Augustus A White, et al.
The Oncologist|September 26, 2012
Phase I study and biomarker analysis of lapatinib and concurrent radiation for locally advanced breast cancerRandall J Kimple, Janet K Horton, Chad A Livasy, et al.
Diabetes Care|November 18, 2024
MODY Calculator and Clinical Features Routinely Used to Distinguish MODY From Type 2 Diabetes in Adults Perform Poorly for Youth Clinically Diagnosed With Type 2 DiabetesRaymond J Kreienkamp, Beverley M Shields, Toni I Pollin, et al.
Pageof 54

Showing results (431-440 of 533) with videos related to

Sort By:
Pageof 54
Diabetologia|June 5, 2024
Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approachLaura M Güdemann, Katie G Young, Nicholas J M Thomas, et al.
American Journal of Pharmaceutical Education|December 5, 2017
Report of the 2016-2017 Student Affairs Standing CommitteeRenae J Chesnut, Iqbal I Atcha, Duc P Do, et al.
Diabetes Care|October 14, 2025
Updating a Clinical Prediction Model for Identifying Monogenic Diabetes to Include Both Clinical Features and BiomarkersJulieanne Knupp, Pedro Cardoso, Katherine G Young, et al.
The Lancet. Primary Care|May 11, 2026
Kidney outcomes with GLP-1 receptor agonists in people with type 2 diabetes already receiving SGLT2 inhibitors: a target trial emulation study using UK primary care dataThijs T Jansz, Andrew P McGovern, Katherine G Young, et al.
The Journal of Clinical Investigation|November 17, 2007
CD200 is induced by ERK and is a potential therapeutic target in melanomaKimberly B Petermann, Gabriela I Rozenberg, Daniel Zedek, et al.
The American Journal of Tropical Medicine and Hygiene|October 17, 2022
What Heterogeneities in Individual-level Mobility Are Lost During Aggregation? Leveraging GPS Logger Data to Understand Fine-scale and Aggregated Patterns of MobilityKathryn L Schaber, Tamaki Kobayashi, Marisa Hast, et al.
Diabetes, Obesity & Metabolism|June 4, 2026
Trends in Second-Line Initiations and Treatment Outcomes Across Age and Frailty Groups in People With Type 2 Diabetes: UK Population-Based Study, 2019-2024M M Dinsdale, K G Young, P Cardoso, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 3, 2009
Integration of racial, cultural, ethnic, and socioeconomic factors into a gastrointestinal pathophysiology courseHelen M Shields, Daniel A Leffler, Augustus A White, et al.
The Oncologist|September 26, 2012
Phase I study and biomarker analysis of lapatinib and concurrent radiation for locally advanced breast cancerRandall J Kimple, Janet K Horton, Chad A Livasy, et al.
Diabetes Care|November 18, 2024
MODY Calculator and Clinical Features Routinely Used to Distinguish MODY From Type 2 Diabetes in Adults Perform Poorly for Youth Clinically Diagnosed With Type 2 DiabetesRaymond J Kreienkamp, Beverley M Shields, Toni I Pollin, et al.
Pageof 54